在synucleinopathy模型中,α-synuclein serine-129酸化的动态可逆性受损
Nagendran Ramalingam1, Lisa Brontesi1, Shan-Xue Jin1
1Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
EMBO reports
|October 23, 2023
概括
在帕金森病中,α-synuclein中的突变会破坏其生理酸化动态. 这种受损的活性依赖酸化和可逆性可能是synucleinopathy病原体的基础.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 在血清-129 (pS129) 的α-synuclein的酸化是帕金森病和相关的synucleinopathies的关键病理标志.
- 最近的发现表明,ps129在激活突触传输方面也起着生理作用,神经元活动触发可逆的ps129.
- 了解ps129的调节对于破译它在正常生理和疾病中的双重作用至关重要.
研究的目的:
- 调查SNCA基因中与帕金森病相关的误解突变如何影响S129.9的活性依赖的α-synuclein酸化.
- 确定这些突变是否影响ps129的可逆性,这是其生理功能的一个关键方面.
- 在同核蛋白病变的背景下探索扰乱ps129动态的含义.
主要方法:
- 利用来自老鼠的原发性皮质神经元.
- 在表达野生型和突变形式的α-synuclein (A30P,H50Q,G51D,A53T,E46K和三重突变"3K") 的神经元中评估了基底和活动依赖的ps129水平.
- 研究了pS129在神经元刺激和抑制后以及在蛋白质酶抑制条件下的可逆性.
主要成果:
- 突变的α-synuclein形式 (A30P,H50Q,G51D) 显示了基底pS129水平的降低,而E46K显示了更高的水平;A53T水平与野生类型相似.
- 突变者A30P和E46K在刺激后表现出ps129的可逆性受损.
- "3K"突变体表现出严重损害的脱化,而pS129因蛋白酶体抑制而过量减少了其可逆性.
结论:
- 与帕金森病相关的SNCA突变破坏了S129.9的α-synuclein酸化的生理动态.
- 活动依赖的酸化和ps129的可逆性受损可能是synucleinopathies的一个共同特征.
- 这些发现表明了针对帕金森病中的α-synuclein酸化动态的新型治疗和诊断策略.
更多相关视频
09:36Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
Published on: August 13, 2017
6.8K
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.8K
相关概念视频
Phosphorylation
50.4K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.4K
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
